Total Payments
$20,772
2024 Payments
$3,579
Companies
65
Transactions
977
Medicare Patients
5,239
Medicare Billing
$763,010
Payment Breakdown by Category
Food & Beverage$20,269 (97.6%)
Education$351.03 (1.7%)
Other$152.09 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,269 | 960 | 97.6% |
| Education | $351.03 | 8 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152.09 | 9 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,297 | 73 | $0 (2024) |
| Biogen, Inc. | $2,216 | 113 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,216 | 82 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,169 | 38 | $0 (2024) |
| Lilly USA, LLC | $1,131 | 49 | $0 (2024) |
| ABBVIE INC. | $1,022 | 59 | $0 (2024) |
| GENZYME CORPORATION | $989.08 | 35 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $735.15 | 48 | $0 (2022) |
| PFIZER INC. | $552.73 | 25 | $0 (2024) |
| EMD Serono, Inc. | $548.34 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,579 | 148 | Lilly USA, LLC ($369.19) |
| 2023 | $3,160 | 149 | Biogen, Inc. ($317.51) |
| 2022 | $3,464 | 171 | Biogen, Inc. ($457.88) |
| 2021 | $2,865 | 149 | Biogen, Inc. ($535.44) |
| 2020 | $1,994 | 109 | Supernus Pharmaceuticals, Inc. ($208.26) |
| 2019 | $2,306 | 92 | UCB, Inc. ($585.53) |
| 2018 | $1,785 | 81 | GENZYME CORPORATION ($231.40) |
| 2017 | $1,620 | 78 | GENZYME CORPORATION ($252.82) |
All Payment Transactions
977 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Neurology | ||||||
| 12/20/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $35.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Neuropsychiatry | ||||||
| 11/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $36.29 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Neurology | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: PAIN | ||||||
| 11/14/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Neurology | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Neurology | ||||||
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.60 | General |
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,460 | 2,018 | $532,408 | $208,397 |
| 2022 | 16 | 1,413 | 2,079 | $506,937 | $208,094 |
| 2021 | 17 | 1,204 | 1,752 | $448,269 | $184,624 |
| 2020 | 28 | 1,162 | 1,683 | $225,403 | $161,894 |
Total Patients
5,239
Total Services
7,532
Medicare Billing
$763,010
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 354 | 555 | $127,095 | $52,279 | 41.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 172 | 188 | $118,816 | $42,939 | 36.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 83 | 88 | $78,672 | $30,246 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 155 | 155 | $54,095 | $19,954 | 36.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 169 | 347 | $44,763 | $17,118 | 38.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 152 | 259 | $22,792 | $11,409 | 50.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 76 | $23,332 | $10,288 | 44.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 23 | 23 | $17,319 | $6,847 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $15,276 | $5,932 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $11,025 | $4,150 | 37.6% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 37 | 38 | $6,612 | $2,616 | 39.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 24 | 27 | $5,454 | $2,109 | 38.7% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 29 | 29 | $3,799 | $1,347 | 35.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 68 | $2,040 | $716.31 | 35.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $798.00 | $388.92 | 48.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 36 | 52 | $520.00 | $58.48 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 328 | 523 | $119,767 | $50,797 | 42.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 156 | 164 | $103,648 | $38,711 | 37.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 78 | 82 | $73,308 | $29,455 | 40.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 175 | 479 | $42,152 | $23,648 | 56.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 175 | 175 | $61,075 | $22,012 | 36.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 144 | 270 | $34,830 | $14,265 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 45 | $13,815 | $6,012 | 43.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 17 | 17 | $12,801 | $5,248 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $13,028 | $4,972 | 38.2% |
About Dr. Lara Fix, DO
Dr. Lara Fix, DO is a Neurology healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043263924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lara Fix, DO has received a total of $20,772 in payments from pharmaceutical and medical device companies, with $3,579 received in 2024. These payments were reported across 977 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($20,269).
As a Medicare-enrolled provider, Fix has provided services to 5,239 Medicare beneficiaries, totaling 7,532 services with total Medicare billing of $763,010. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Stuart, FL
- Active Since 05/19/2006
- Last Updated 08/14/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1043263924
Products in Payments
- Briviact (Drug) $1,883
- TYSABRI (Biological) $1,217
- AUBAGIO (Drug) $904.93
- NURTEC ODT (Drug) $781.56
- UBRELVY (Drug) $700.61
- TROKENDI XR (Drug) $691.96
- KESIMPTA (Drug) $681.70
- EMGALITY (Drug) $659.66
- Leqembi (Drug) $490.63
- AUSTEDO (Drug) $486.97
- RYTARY (Drug) $485.22
- APTIOM (Drug) $421.22
- NUEDEXTA (Drug) $391.93
- QULIPTA (Drug) $368.42
- INGREZZA (Drug) $340.58
- MAYZENT (Drug) $333.53
- Aimovig (Biological) $306.82
- GOCOVRI (Drug) $305.15
- REXULTI (Drug) $304.66
- ADUHELM (Biological) $304.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Stuart
Dr. Sunil Chauhan, Md, MD
Neurology — Payments: $70,847
Neurology $70,847
Henry Calas, Md, MD
Neurology — Payments: $20,459
Neurology $20,459
Paul Elliott, Do, DO
Neurology — Payments: $19,557
Neurology $19,557
Daniela Saadia, Md, MD
Neurology — Payments: $11,772
Neurology $11,772
Alyssa Starek, Pa, PA
Neurology — Payments: $8,458
Neurology $8,458
Joshua Leibner, M.d, M.D
Neurology — Payments: $2,533
Neurology $2,533